基于2021年GOLD《COPD诊断、治疗与预防全球策略》解析慢性阻塞性肺疾病稳定期非药物管理策略

2021-11-08 贵州中医药大学第一附属医院急诊科中国全科医学

慢性阻塞性肺疾病(COPD)是世界第三大死因,仅次于缺血性心脏病和卒中。但面对这个可防、可治的重大公共卫生问题,我国临床诊疗仍存在诸多如健康教育不足、随访缺失、临床管理不规范等问题,以上均可能是病情加

中文标题：

发布机构：

贵州中医药大学第一附属医院急诊科

发布日期：

2021-11-08

简要介绍：

慢性阻塞性肺疾病(COPD)是世界第三大死因,仅次于缺血性心脏病和卒中。但面对这个可防、可治的重大公共卫生问题,我国临床诊疗仍存在诸多如健康教育不足、随访缺失、临床管理不规范等问题,以上均可能是病情加重的重要原因,致使后期治疗效果欠佳、难度增大,以及社会经济负担增加等。故加快促进临床管理的规范化,提高诊疗精度和效度具有重要的现实意义。本文基于2021年慢性阻塞性肺疾病全球倡议(GOLD)《COPD诊断、治疗与预防全球策略》指南,结合我国临床诊疗现状和疾病研究进展,针对COPD稳定期非药物管理策略进行解析,包括肺功能测定和评估、减少危险因素暴露、肺康复、氧疗、无创通气和外科治疗,以期为我国临床医师的实践工作提供参考,优化临床疗效。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=731b11c00233328d, title=基于2021年GOLD《COPD诊断、治疗与预防全球策略》解析慢性阻塞性肺疾病稳定期非药物管理策略, enTitle=, guiderFrom=中国全科医学, authorId=0, author=, summary=慢性阻塞性肺疾病(COPD)是世界第三大死因,仅次于缺血性心脏病和卒中。但面对这个可防、可治的重大公共卫生问题,我国临床诊疗仍存在诸多如健康教育不足、随访缺失、临床管理不规范等问题,以上均可能是病情加, cover=https://img.medsci.cn/2022122/1642859250824_5579292.jpg, journalId=0, articlesId=null, associationId=2339, associationName=贵州中医药大学第一附属医院急诊科, associationIntro=贵州中医药大学第一附属医院急诊科, copyright=0, guiderPublishedTime=Mon Nov 08 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">慢性阻塞性肺疾病(COPD)是世界第三大死因,仅次于缺血性心脏病和卒中。但面对这个可防、可治的重大公共卫生问题,我国临床诊疗仍存在诸多如健康教育不足、随访缺失、临床管理不规范等问题,以上均可能是病情加重的重要原因,致使后期治疗效果欠佳、难度增大,以及社会经济负担增加等。故加快促进临床管理的规范化,提高诊疗精度和效度具有重要的现实意义。本文基于2021年慢性阻塞性肺疾病全球倡议(GOLD)《COPD诊断、治疗与预防全球策略》指南,结合我国临床诊疗现状和疾病研究进展,针对COPD稳定期非药物管理策略进行解析,包括肺功能测定和评估、减少危险因素暴露、肺康复、氧疗、无创通气和外科治疗,以期为我国临床医师的实践工作提供参考,优化临床疗效。 </span></p>, tagList=[TagDto(tagId=2115, tagName=慢性阻塞性肺疾病), TagDto(tagId=25771, tagName=慢性阻塞性肺疾病（COPD）), TagDto(tagId=117733, tagName=慢性阻塞性肺疾病与肺心病)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3652, appHits=214, showAppHits=0, pcHits=485, showPcHits=3433, likes=1, shares=23, comments=5, approvalStatus=1, publishedTime=Sat Jan 22 21:44:56 CST 2022, publishedTimeString=2021-11-08, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Sat Jan 22 21:46:50 CST 2022, updatedBy=4754896, updatedName=小小医者, updatedTime=Thu Jan 04 16:41:37 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=基于2021年GOLD《COPD诊断、治疗与预防全球策略》解析慢性阻塞性肺疾病稳定期非药物管理策略.pdf)])

基于2021年GOLD《COPD诊断、治疗与预防全球策略》解析慢性阻塞性肺疾病稳定期非药物管理策略.pdf

下载请点击：

评论区 (4)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1202469, encodeId=31d4120246916, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72615611943, createdName=ms8000001209014685, createdTime=Mon Mar 14 14:09:13 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190766, encodeId=6ec41190e66b4, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0391651C5784486DC064FF0CC8D8CF2C/100, createdBy=df4d2418589, createdName=高寒, createdTime=Mon Feb 07 16:43:36 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189382, encodeId=7e9a118938287, content=想要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a225177122, createdName=冷文华, createdTime=Sun Jan 30 22:55:38 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188370, encodeId=d67211883e07e, content=写的特别好。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dde2904362, createdName=faanchzh, createdTime=Wed Jan 26 18:24:39 CST 2022, time=2022-01-26, status=1, ipAttribution=)]
2022-03-14 ms8000001209014685

学习

51 0
[GetPortalCommentsPageByObjectIdResponse(id=1202469, encodeId=31d4120246916, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72615611943, createdName=ms8000001209014685, createdTime=Mon Mar 14 14:09:13 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190766, encodeId=6ec41190e66b4, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0391651C5784486DC064FF0CC8D8CF2C/100, createdBy=df4d2418589, createdName=高寒, createdTime=Mon Feb 07 16:43:36 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189382, encodeId=7e9a118938287, content=想要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a225177122, createdName=冷文华, createdTime=Sun Jan 30 22:55:38 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188370, encodeId=d67211883e07e, content=写的特别好。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dde2904362, createdName=faanchzh, createdTime=Wed Jan 26 18:24:39 CST 2022, time=2022-01-26, status=1, ipAttribution=)]
2022-02-07 高寒

学习学习

53 0
[GetPortalCommentsPageByObjectIdResponse(id=1202469, encodeId=31d4120246916, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72615611943, createdName=ms8000001209014685, createdTime=Mon Mar 14 14:09:13 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190766, encodeId=6ec41190e66b4, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0391651C5784486DC064FF0CC8D8CF2C/100, createdBy=df4d2418589, createdName=高寒, createdTime=Mon Feb 07 16:43:36 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189382, encodeId=7e9a118938287, content=想要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a225177122, createdName=冷文华, createdTime=Sun Jan 30 22:55:38 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188370, encodeId=d67211883e07e, content=写的特别好。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dde2904362, createdName=faanchzh, createdTime=Wed Jan 26 18:24:39 CST 2022, time=2022-01-26, status=1, ipAttribution=)]
2022-01-30 冷文华

想要

63 0
[GetPortalCommentsPageByObjectIdResponse(id=1202469, encodeId=31d4120246916, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72615611943, createdName=ms8000001209014685, createdTime=Mon Mar 14 14:09:13 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190766, encodeId=6ec41190e66b4, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0391651C5784486DC064FF0CC8D8CF2C/100, createdBy=df4d2418589, createdName=高寒, createdTime=Mon Feb 07 16:43:36 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189382, encodeId=7e9a118938287, content=想要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a225177122, createdName=冷文华, createdTime=Sun Jan 30 22:55:38 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188370, encodeId=d67211883e07e, content=写的特别好。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dde2904362, createdName=faanchzh, createdTime=Wed Jan 26 18:24:39 CST 2022, time=2022-01-26, status=1, ipAttribution=)]
2022-01-26 faanchzh

写的特别好。

60 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

呼吸指南

基于2021年GOLD《COPD诊断、治疗与预防全球策略》解析慢性阻塞性肺疾病稳定期非药物管理策略

相关指南

科室

工具

服务